Cite
Takeda K, LaFrance ND, Weisman HF, et al. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction. J Am Coll Cardiol. 1991;17(2):519-26doi: 10.1016/s0735-1097(10)80125-1.
Takeda, K., LaFrance, N. D., Weisman, H. F., Wagner, H. N., & Becker, L. C. (1991). Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction. Journal of the American College of Cardiology, 17(2), 519-26. https://doi.org/10.1016/s0735-1097(10)80125-1
Takeda, K, et al. "Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction." Journal of the American College of Cardiology vol. 17,2 (1991): 519-26. doi: https://doi.org/10.1016/s0735-1097(10)80125-1
Takeda K, LaFrance ND, Weisman HF, Wagner HN, Becker LC. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction. J Am Coll Cardiol. 1991 Feb;17(2):519-26. doi: 10.1016/s0735-1097(10)80125-1. PMID: 1846888.
Copy
Download .nbib